On November 13, 2023, China's National Health Commission scientists revealed a surge in respiratory infections, presumably triggered by the re-emergence of known pathogens post the ease of COVID-19 restrictions.
On November 21, the international infectious disease surveillance network, ProMED, echoed a report from a Chinese media outlet detailing the struggle of hospitals in Beijing and other northern cities with a sudden influx of indeterminate origin pneumonia cases in children. On November 22, in line with its surveillance of potential new pandemic threats, the WHO requested additional information on the issue.
The symptoms as reported by ProMED include fever, absence of cough, and the detection of lung nodules - localized areas of denser lung tissue, visible via X-ray. These formations, generally benign and common, are indicative of bacterial infections, although they can occur post a bacterial infection succeeding a viral episode like influenza.
The primary suspect is Mycoplasma pneumoniae, a common bacterium that primarily affects the upper respiratory tract and frequently triggers pneumonia in children. However, the formation of lung nodules isn't typical for Mycoplasma, which usually generates irregular pulmonary infiltrates (opaque areas in the tissues). Yet, it's plausible for it to evolve into an atypical form.
Supporting the Mycoplasma pneumoniae hypothesis is a similar pediatric pneumonia outbreak in South Korea, with about 200 cases, attributed to this bacterium. It's probable that the Chinese cases have a similar origin.
Increased circulation of respiratory pathogens is typical during the winter season, especially in China, now experiencing its first cold season without COVID-19 restrictions. Many children, due to years of isolation, lack immune memory against common pediatric infections. A similar situation was previously linked to an alleged, but later refuted, rise in pediatric hepatitis in Europe.
If these cases are indeed bacterial pneumonias, apprehensions regarding potential new pandemics could be lessened. Bacteria generally disseminate much slower than viruses, and we have an extensive array of antibiotics to combat them. Initial observations suggest it's unlikely to be a completely new pathogen, as that would result in a larger patient population, including adults.
Post a Comment